You are using an outdated browser. Please upgrade your browser to improve your experience.
substance withdrawal syndrome
Disease Summary
Associated Targets (79)
Tclin
32
Tbio
27
Tchem
20
Mondo Description A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions.
Disease Ontology Description A substance-related disorder that occurs upon the abrupt discontinuation/separation or a decrease in dosage of the intake of medications, recreational drugs, and alcohol.
Counts of Target Development Levels for diseases known to be associated with this disease. If the disease has a valid DOID, targets known to be associated with all child diseases are aggregated. Click "Explore Associated Targets" to view more facets and details for the target list.
Description from Mondo Disease Ontology.
Description from Disease Ontology
DataSources which have contributed target associations to this disease, and the identifiers by which the disease is referenced.
DOID:0060001
EFO:0005800
ICD9:292.0
MESH:D013375
NCIT:C35046
SCTID:363101005
UMLS:C0152128
MONDO:0005567
High level summary of knowledge for a disease, including descriptions and datasource references.